Related references
Note: Only part of the references are listed.Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis
John L. Wallace et al.
GASTROENTEROLOGY (2011)
Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy
Shunji Fujimori et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis
Akira Andoh et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Koji Atarashi et al.
SCIENCE (2011)
Rebamipide: a gastrointestinal protective drug with pleiotropic activities
Yuji Naito et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Recent Advances in Molecular Approaches to Gut Microbiota in Inflammatory Bowel Disease
Akira Andoh et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Advances in the use of terminal restriction fragment length polymorphism (T-RFLP) analysis of 16S rRNA genes to characterize microbial communities
Ursel M. E. Schutte et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2008)
Microbial influences in inflammatory bowel diseases
R. Balfour Sartor
GASTROENTEROLOGY (2008)
Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study
Yasumasa Niwa et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Prostaglandins, NSAIDs, and gastric mucosal protection: Why doesn't the stomach digest itself?
John L. Wallace
PHYSIOLOGICAL REVIEWS (2008)
Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent
T. Watanabe et al.
GUT (2008)
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population:: a randomized, double-blind, placebo-controlled trial
Akira Terano et al.
JOURNAL OF GASTROENTEROLOGY (2007)
Optimization of terminal restriction fragment polymorphism (TRFLP) analysis of human gut microbiota
Fei Li et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2007)
Diversity of the Clostridium coccoides group in human fecal microbiota as determined by 16S rRNA gene library
H Hayashi et al.
FEMS MICROBIOLOGY LETTERS (2006)
Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism
H Hayashi et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Diversity of the human intestinal microbial flora
PB Eckburg et al.
SCIENCE (2005)
Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota
M Matsumoto et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2005)
A quantitative analysis of NSAID-Induced small bowel pathology by capsule enteroscopy
L Maiden et al.
GASTROENTEROLOGY (2005)
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo
JL Goldstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial Populations in human Feces
K Nagashima et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2003)
Terminal restriction fragment length polymorphism analysis for human fecal microbiota and its application for analysis of complex bifidobacterial communities
M Sakamoto et al.
MICROBIOLOGY AND IMMUNOLOGY (2003)
Application of terminal RFLP analysis to characterize oral bacterial flora in saliva of healthy subjects and patients with periodontitis
M Sakamoto et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: A key to nonsteroidal anti-inflammatory drug-induced intestinal damage
A Tanaka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Protective effect of rebamipide on indomethacin-induced intestinal damage in rats
H Mizoguchi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Terminal restriction fragment length polymorphism analysis program, a web-based research tool for microbial community analysis
TL Marsh et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
Share Paper
